Board, C-suite, and senior level assignments across a broad range of functions globally. Justine’s deep scientific knowledge combined with her capital markets background and leadership consulting experience enables her to bring her clients a unique perspective.
Justine focuses on advising innovative organizations with R&D at their core across the global pharmaceutical, biotech, life sciences, generics, consumer health, agtech and food tech industries. Justine joined Coulter Partners in 2022, based in London.
Board and C-suite search and consulting. Pharma. Biotech. Life Sciences. Specialized generics. Consumer health. Agtech and Food Tech.
As a banker with SG Cowen in the early 2000s, Justine advised biotech companies on cross-border M&A and international fundraising. She then spent a decade at Brunswick Group where she co-led the international healthcare team, working with pharma and biotech companies in the US and Europe on the critical communications aspects of agreed and hostile M&A transactions, as well as crafting equity stories ahead of IPOs and private financing rounds. Most recently at MWM, she focused on building boards and senior leadership teams for some of the world’s largest healthcare companies as well as many PE-backed growth companies. Justine holds a BSc in Pharmacology and a PhD in Molecular Therapeutics from the University of Edinburgh, UK.
London (European Headquarters),
BIA Gala Dinner
26 January 2023
Coulter Partners attends Association of Executive Search and Leadership Consultants (AESC) Global Conference Sustaining Growth
16 November 2022
Coulter Partners expands its global team with thirteen further appointments in the UK, France, Italy, and the US
15 November 2022
AESC Global Conference - Sustaining Growth
15 November 2022
Coulter Partners announces the appointment of Dr. Justine McIlroy as Client Partner
22 September 2022